Blood samples were obtained from the 11 patients at the following times: 0.5, 1, 2, 3, 6, 12, 24, 36, 48, 72, and 96 h after iopamidol administration.
Total dialysate and urine were collected every 24 h for the 4 days following administration.
With the increased incidence of chronic renal failure, radiocontrast studies are important for diagnosis and treatment.
Therefore, the use of iodinated radiocontrast media in computed tomography (CT) and angiography is often required in these patients [1–3].
This study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Ethical Committee at the Akita City Hospital. Eleven patients in the non-HD group who participated in the clearance of iopamidol analysis. Forty-four patients who underwent a total of 58 angiographic CT scans did not undergo HD treatment (the non-HD group), and six patients who underwent six angiographic CT scans underwent HD treatment (the immediate HD group).In this study, we evaluated the clearance of iopamidol, a low osmolar nonionic iodinated radiocontrast media, and the incidence of adverse events associated with its use in CAPD patients.Between 20, 50 patients who had undergone a total of 64 angiographic CT scans while receiving CAPD at the Akita City Hospital and the Oyokyo Kidney Research Institute were enrolled in the study (Figure 1).Online means tools are an administration way to impartial potential dates.